2020
Unraveling the mechanism of recognition of the 3’ splice site of the adenovirus major late promoter intron by the alternative splicing factor PUF60
Hsiao HT, Crichlow GV, Murphy JW, Folta-Stogniew EJ, Lolis EJ, Braddock DT. Unraveling the mechanism of recognition of the 3’ splice site of the adenovirus major late promoter intron by the alternative splicing factor PUF60. PLOS ONE 2020, 15: e0242725. PMID: 33253191, PMCID: PMC7703929, DOI: 10.1371/journal.pone.0242725.Peer-Reviewed Original Research
2008
Histopathologic and Molecular Aspects of CD56+ Natural Killer/ T-Cell Lymphoma of the Testis
Ornstein DL, Bifulco CB, Braddock DT, Howe JG. Histopathologic and Molecular Aspects of CD56+ Natural Killer/ T-Cell Lymphoma of the Testis. International Journal Of Surgical Pathology 2008, 16: 291-300. PMID: 18573785, DOI: 10.1177/1066896907309687.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCD56 AntigenCombined Modality TherapyCyclophosphamideDexamethasoneDoxorubicinHumansImmunohistochemistryIn Situ HybridizationKiller Cells, NaturalLymphoma, T-Cell, PeripheralMaleOrchiectomyRNA, ViralTesticular NeoplasmsVincristineConceptsNatural killer/T-cell lymphomaNasal-type natural killer/T-cell lymphomaT-cell lymphomaCytoplasmic CD3Secondary testicular involvementAggressive clinical courseEpstein-Barr virusT-cell antigensT-cell receptor genesB-cell counterpartsComprehensive histopathologicSurface CD56Nasal typeTesticular involvementClinical coursePrimary presentationRare malignancyMonoclonal rearrangementLymphomaYounger ageReceptor geneCD56HistopathologicVariable expressionCD3